Patents by Inventor Jay Powers

Jay Powers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl sulfonamide compounds and uses related thereto
    Publication number: 20050277649
    Abstract: The present invention provides Aryl Sulfonamide Compounds having the formula: and prodrugs or pharmaceutically acceptable salts or prodrugs thereof. The Aryl Sulfonamide Compounds are useful for treating diabetes, obesity, and other diseases and disorders.
    Type: Application
    Filed: December 20, 2004
    Publication date: December 15, 2005
    Applicants: Amgen SF, LLC, Japan Tobacco, Inc.
    Inventors: Michael DeGraffenreid, Xiao He, Jay Powers, Daqing Sun, Xuelei Yan
  • Arylsulfones and uses related thereto
    Publication number: 20050277665
    Abstract: Aryl sulfone compounds of formula I and II are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders:
    Type: Application
    Filed: April 14, 2005
    Publication date: December 15, 2005
    Inventors: Pingchen Fan, Hiroyuki Goto, Xiao He, Makoto Kakutani, Marc Labelle, Dustin McMinn, Jay Powers, Yosup Rew, Daqing Sun, Xuelei Yan
  • Pyrazole compounds and uses related thereto
    Publication number: 20050272793
    Abstract: Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.
    Type: Application
    Filed: March 18, 2005
    Publication date: December 8, 2005
    Applicant: Amgen Inc.
    Inventors: Hiroyuki Goto, Makoto Kakutani, Jun Nishiu, Yasuhiro Ohe, Jay Powers, Shinji Yata
  • Inflammation modulators
    Publication number: 20030181472
    Abstract: Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain quinoline or quinazoline rings.
    Type: Application
    Filed: December 4, 2002
    Publication date: September 25, 2003
    Applicant: Tularik Inc.
    Inventors: David L. Clark, Timothy D. Cushing, Michael R. DeGraffenreid, Xiaolin Hao, Xiao He, Juan C. Jaen, Marc Labelle, Jay Powers, Marie-Louise Smith, Craig S. Tomooka, Nigel P.C. Walker, Adrian L. Gill, Francisco X. Talamas, Sharada Labadie